ION BLUE EncyclopediaHigh Evidence

Palmitoyl Oligopeptide

Palmitoyl oligopeptide is a lipidated peptide cosmetic ingredient, cited within a peptide blend with palmitoyl tetrapeptide-7. Evidence is from a multi-ingredient blend, so effects cannot be attributed to palmitoyl oligopeptide alone.

Evidence: Low

Reading time:1 min
Citations:1
Updated:June 29, 2026

Type

Peptide

Direct Answer

Palmitoyl oligopeptide is a lipidated peptide cosmetic ingredient, cited within a peptide blend with palmitoyl tetrapeptide-7. Evidence is from a multi-ingredient blend, so effects cannot be attributed to palmitoyl oligopeptide alone.

Summary Table

Evidence Level

High

Key Information

Classification

Signal Peptides1 Mechanisms

Key Takeaways

  • Palmitoyl oligopeptide is a cosmetic peptide used in blends
  • Cited evidence is from a multi-ingredient blend (with palmitoyl tetrapeptide-7)
  • Effects cannot be attributed to this peptide alone

Scientific Overview

In Plain English

Palmitoyl oligopeptide is a peptide used in anti-aging skincare, usually in blends. The cited study tested it together with another peptide, so any benefit cannot be credited to this one ingredient.

Scientific Details

Palmitoyl oligopeptide is a palmitoylated peptide used in cosmetics. A study using ex vivo immunohistochemistry and in vivo human evaluation of a blend of palmitoyl oligopeptide and palmitoyl tetrapeptide-7 reported improved extracellular-matrix structure versus placebo, which the authors described as preliminary. Because it was a blend, effects cannot be attributed to palmitoyl oligopeptide alone.

How It Works

Palmitoyl oligopeptide is described in relation to dermal extracellular-matrix signaling; the cited study evaluated it within a peptide blend rather than in isolation.

Mechanism of Action

Extracellular-matrix signaling (formulation-level)

cell

A blend containing palmitoyl oligopeptide was associated with extracellular-matrix changes in ex vivo and in vivo evaluation; the individual peptide effect was not isolated.

Evidence Level

Human Evidence

In vivo human evaluation of a peptide blend reported improved extracellular-matrix structure versus placebo, described as preliminary.

Cell Evidence

Ex vivo immunohistochemistry on skin explants examined matrix-protein changes for the blend.

Limitations

Evidence is from a blend; effects cannot be attributed to palmitoyl oligopeptide alone, and the authors described findings as preliminary. The cited study is manufacturer-funded (Sederma).

References

  1. Evaluation of dermal extracellular matrix and epidermal-dermal junction modifications using cosmetic peptides. Journal of Cosmetic Dermatology.Cell / In Vitrodoi:10.1111/jocd.12135

Alternative Names

  • Pal-oligopeptide
  • palmitoyl tripeptide complex

Claim Boundaries

ION BLUE is an educational research aggregator. This content summarizes published scientific literature. It is not medically reviewed, is not medical advice, and is not a recommendation to use any substance. Several peptides discussed are research chemicals not approved for human use. Consult a licensed healthcare provider. Cited evidence is from a peptide blend; this entry does not attribute effects to this peptide alone and is not a recommendation to use it.

This page summarizes published research and is for informational purposes only; it is not medical advice.